Please assess the completion status of the following clinical trial:

Trial Title: Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria (main):~* \> 4 watery/soft stools on at least 4 days in the week prior to baseline~* \> 3 stools per day on average within the last 7 days prior to baseline~* Symptoms (chronic watery diarrhea) for at least 3 months before baseline~* Complete colonoscopy within the last 12 weeks before baseline~* Histologically confirmed diagnosis of collagenous colitis~Exclusion Criteria:~* Evidence of infectious diarrhea~* Celiac disease~* Endoscopic-histologic findings, which may have caused diarrhea~* History of partial colonic resection~* Diarrhea as a result of the presence of other symptomatic organic disease of the gastrointestinal tract~* Active colorectal cancer or a history of colorectal cancer~* Severe co-morbidity substantially reducing life expectancy~* Abnormal hepatic function or liver cirrhosis (ALT, AST or AP \>= 2 x ULN)~* Abnormal renal function (Cystatin C \> ULN)~* Active peptic ulcer disease, local intestinal infection~* Asthma, diabetes mellitus, infection, osteoporosis, glaucoma, cataract, or cardiovascular disease if careful medical monitoring is not ensured~* Hemorrhagic diathesis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- A (Type: EXPERIMENTAL): None
- B (Type: EXPERIMENTAL): None
- C (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).